Artificial Lift Systems market was valued at $9.7 billion in 2025 and is projected to reach $16.7 billion by 2035, growing at a CAGR of 5.7% from 2026 to 2035. The market growth is strongly supported by increasing global oil production demand and the rising need to enhance recovery rates from mature oilfields. Artificial lift systems play a critical role in maintaining production levels by improving reservoir pressure and enabling efficient hydrocarbon extraction. A key macro driver accelerating market expansion is the sustained global demand for crude oil and energy security. In April 2024, SLB launched two advanced artificial lift systems—Reda Agile ESP and Reda PowerEdge ESPCP—designed to boost production efficiency while significantly reducing emissions. These technologies integrate real-time digital monitoring to enhance operational stability, lower costs, and cut CO? emissions by up to 55%. The Agile ESP system has already demonstrated success with Pertamina, delivering sustained performance in a challenging offshore well. These innovations improve production economics, extend well life, and enable more energy-efficient operations, aligning with the growing need for efficient extraction from aging reservoirs.

Antimalarial drugs market was valued at $1.5 billion in 2025 and is projected to reach $2.6 billion by 2035, expanding at a CAGR of 5.3% during the forecast period (2026–2035). The market growth is primarily driven by the persistent global burden of malaria and increasing efforts toward disease elimination across endemic regions. According to the World Health Organization (WHO), global malaria funding reached approximately $4.0 billion in 2023, reflecting continued international commitment toward malaria control and elimination. However, this remains significantly below the estimated $7.8 billion required annually by 2025 to stay on track with global eradication targets. This widening funding gap is driving governments and international organizations to increase investments in cost-effective and scalable antimalarial drug procurement, thereby boosting market demand.

Antibiotics market was valued at $52.9 billion in 2025 and is anticipated to reach $75.2 billion by 2035, expanding at a CAGR of 3.7% from 2026 to 2035. Market growth is primarily driven by the sustained prevalence of infectious diseases and the rising threat of antimicrobial resistance (AMR), which continues to challenge global healthcare systems. According to the World Health Organization, lower respiratory infections remain among the leading causes of mortality worldwide, thereby maintaining consistent demand for antibiotic treatments across both hospital and outpatient settings. Furthermore, estimates from the Organisation for Economic Co-operation and Development suggest that antimicrobial resistance could result in approximately 2.4 million deaths across Europe, North America, and Australia by 2050, emphasizing the urgent need for effective and innovative antibiotic therapies. In addition, the growing number of hospital admissions and surgical procedures is contributing to increased antibiotic consumption, particularly in intensive care and post-operative care settings. Among drug classes, beta-lactams continue to dominate the market due to their broad-spectrum efficacy, safety profile, and cost-effectiveness, while respiratory tract infections represent the largest application segment globally.

Alcoholic Beverages Market size was valued at $4.0 billion in 2025 and is projected to reach $17.5 billion by 2035, growing at a CAGR of 16% between 2026 and 2035. The market growth is primarily driven by increasing global alcohol consumption, premiumization trends, and expanding distribution channels across both developed and emerging economies. A key macro driver supporting market expansion is the rising global alcohol consumption and urban lifestyle shifts. According to the World Health Organization (WHO), global per capita alcohol consumption is estimated at around 5.5 litres of pure alcohol per year, highlighting a large and stable consumer base.

Advanced Therapy Medicinal Products (ATMP) market was valued at $28.5 billion in 2025 and is projected to reach $147.4 billion by 2035, growing at a CAGR of 17.9% during 2026–2035. Advanced Therapy Medicinal Products include gene therapy, cell therapy, tissue-engineered products, and combined ATMPs that integrate biological components with medical devices. These therapies are primarily used in the treatment of oncology, rare genetic disorders, cardiovascular diseases, neurological conditions, and immunological disorders. ATMPs are developed through advanced biotechnological processes involving genetic modification, cellular engineering, and regenerative medicine approaches. ATMPs play an indispensable role in modern healthcare by offering targeted, personalized, and potentially curative treatments.

3D printing material market size was valued at $4.0 billion in 2025 and is projected to reach $17.5 billion by 2035, growing at a CAGR of 16% between 2026 and 2035. 3D printing materials, including plastics/polymers, metals, ceramics, composites, bio-materials, and specialty materials, are essential components in additive manufacturing processes. These materials enable the production of complex geometries, lightweight structures, and customised products across industries such as aerospace, healthcare, automotive, and industrial manufacturing. With increasing demand for rapid prototyping, cost-efficient production, and sustainable manufacturing, the adoption of advanced 3D printing materials is accelerating globally.

Network monitoring market was valued at $9.8 billion in 2025 and is projected to reach $28.2 billion by 2035, growing at a CAGR of 11.2% during the forecast period (2026-2035). Organizations are prioritizing intelligent solutions to ensure continuous performance, reliability, and operational efficiency. The growing dependence on hybrid and cloud-based infrastructures is further accelerating the need for innovative monitoring capabilities. The introduction of AI-driven autonomous monitoring platforms is contributing significantly to the evolution of the global network monitoring market. Vendors are focusing on embedding artificial intelligence to enable predictive insights, faster troubleshooting, and reduced operational burden. This transition reflects the rising demand for proactive and self-sustaining monitoring environments across enterprises. In February, 2026, Dynatrace introduced Dynatrace Intelligence, an advanced AI layer designed to strengthen network monitoring through autonomous analysis and remediation. 

Nasal spray market was valued at $14.8 billion in 2025 and is projected to reach $30.7 billion by 2035, growing at a CAGR of 7.6% during the forecast period (2026-2035). The global nasal spray market experienced substantial growth, driven by the rising prevalence of respiratory disorders, particularly asthma. Asthma, a chronic inflammation of the lung airways, caused symptoms such as coughing, wheezing, chest tightness, and shortness of breath, affecting millions worldwide. By 2025, an estimated 280 million individuals were living with asthma, with urbanization, air pollution, and modern lifestyle factors contributing significantly to this increase. In the US, approximately 24.9 million individuals, or 7.7% of the population, had asthma by 2025, with adults accounting for 20.2 million of the total. Prevalence was higher among adults (8.0%) than children (6.5%) and disproportionately affected females (9.7%) compared to males (6.2%). Asthma patients accounted for over 900,000 emergency department visits and 94,000 hospital inpatient stays annually, imposing an economic burden estimated at $50 billion. More than 3,500 fatalities occurred each year due to asthma, with older adults being the most affected.

Military embedded market was valued at $4.8 billion in 2025 and is projected to reach $10.4 billion by 2035, growing at a CAGR of 8.2% during the forecast period (2026-2035). The integration of Artificial Intelligence (AI) into embedded defense systems is becoming a defining trend in modern military technology, enabling enhanced data processing and real-time decision-making capabilities. Nations such as the United States continue to lead in defense-related AI investments, reflecting a broader shift toward advanced digital warfare capabilities. A growing share of defense expenditure is being directed toward AI, autonomous systems, and high-performance computing technologies. The Department of Defense’s total IT budget reached $66 billion, marking an increase of $1.8 billion from 2025, with all service branches expanding their focus on AI-driven initiatives. Notably, the Navy alone recorded an additional $308 million in AI spending, representing a year-over-year increase of 22.7%. This sustained rise in investment highlights the increasing importance of intelligent systems in enhancing operational efficiency and decision-making.

Medical Devices market was valued at $721.2 billion in 2025 and is projected to reach $1,362.2 billion by 2035, growing at a CAGR of 12.4% during the forecast period (2026-2035). Policy-driven initiatives by governments are playing a critical role in shaping the growth trajectory of the medical devices market. These measures are creating a strong foundation for technological advancement and sectorial growth. In nation such as India, programs like Production-Linked Incentive scheme, establishment of medical device parks, and 100% FDI under the automatic route are strengthening domestic manufacturing capabilities. The Union Budget 2025-26 allocated $11.48 billion to healthcare, demonstrating a strong commitment to research, infrastructure, and innovation.